TargED
ID: 7648370Developer of an antibody-enzyme fusion protein aimed at treating various thrombotic events
3
Funding Rounds
$69.0m
Money raised
Recent Funding Rounds
Overview
Developer of an antibody-enzyme fusion protein aimed at treating various thrombotic events
- Website:
- Headquarters: Utrecht
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Kr***** Ve******** |
|
- | |
| Ma** va* Mo***** | - | - | |
| St**** de Ma** |
|
- | |
| Co** Ma** | - | - |
Funding
Funding series
Funding Series Analysis
The company TargED has raised a total of $69m in funding over 3 rounds.
Key Insights:
- TargED Series A Round, December 2025: $25m
- TargED Biopharmaceuticals February 2022 Series A Funding Round: $44m
Industries
TargED is active in the following industries: